111 Total Liabilities and Share Holders Equity 2018-2026 | YI

111 total liabilities and share holders equity from 2018 to 2026. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
111 Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $382
2023 $435
2022 $504
2021 $494
2020 $464
2019 $231
2018 $225
2017 $115
111 Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2026-03-31 $280
2025-12-31 $315
2025-09-30 $349
2025-06-30 $346
2025-03-31 $359
2024-12-31 $382
2024-09-30 $432
2024-06-30 $384
2024-03-31 $405
2023-12-31 $435
2023-09-30 $461
2023-06-30 $421
2023-03-31 $472
2022-12-31 $504
2022-09-30 $429
2022-06-30 $463
2022-03-31 $475
2021-12-31 $494
2021-09-30 $486
2021-06-30 $511
2021-03-31 $470
2020-12-31 $464
2020-09-30 $401
2020-06-30 $267
2020-03-31 $233
2019-12-31 $231
2019-09-30 $234
2019-06-30 $253
2019-03-31 $239
2018-09-30 $247
2017-12-31 $115
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.057B $1.795B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $24.733B 27.19
Tempus AI (TEM) United States $7.677B 0.00
Hims & Hers Health (HIMS) United States $4.429B 38.86
Doximity (DOCS) United States $3.888B 16.84
IRhythm Holdings (IRTC) United States $3.724B 0.00
10x Genomics (TXG) United States $2.973B 0.00
Privia Health (PRVA) United States $2.810B 131.59
Hinge Health (HNGE) United States $2.789B 0.00
Heartflow (HTFL) United States $2.311B 0.00
Omnicell (OMCL) United States $1.564B 43.00
Inspire Medical Systems (INSP) United States $1.555B 20.94
Enovis (ENOV) United States $1.405B 7.40
Butterfly Network (BFLY) United States $1.047B 0.00
Azenta (AZTA) United States $1.023B 41.13
Clover Health Investments (CLOV) United States $1.013B 0.00
Talkspace (TALK) United States $0.864B 103.40
Schrodinger (SDGR) United States $0.839B 0.00
Phreesia (PHR) United States $0.490B 50.38
Fulgent Genetics (FLGT) United States $0.429B 0.00
Standard BioTools (LAB) United States $0.345B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.322B 0.00
CapsoVision (CV) United States $0.311B 0.00
Senseonics Holdings (SENS) United States $0.279B 0.00
Claritev (CTEV) United States $0.269B 0.00
TruBridge (TBRG) United States $0.268B 8.60
Evolent Health (EVH) United States $0.260B 0.00
Carlsmed (CARL) United States $0.239B 0.00
KORU Medical Systems (KRMD) United States $0.196B 0.00
Zepp Health (ZEPP) Netherlands $0.189B 0.00
CareCloud (CCLD) United States $0.115B 8.18
Nyxoah SA (NYXH) Belgium $0.111B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
American Well (AMWL) United States $0.086B 0.00
Outset Medical (OM) United States $0.077B 0.00
Health Catalyst (HCAT) United States $0.073B 0.00
Pulmonx (LUNG) United States $0.058B 0.00
NetraMark Holdings (AINMF) Canada $0.052B 0.00
Precipio (PRPO) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.047B 0.00
Evaxion - (EVAX) Denmark $0.034B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
P3 Health Partners (PIII) United States $0.018B 0.00
EUDA Health Holdings (EUDA) Singapore $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.009B 0.00
Zhongchao (ZCMD) China $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
PROFUSA (PFSA) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00